KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Return on Invested Capital (2016 - 2019)

Palvella Therapeutics (PVLA) has disclosed Return on Invested Capital for 6 consecutive years, with 1.91% as the latest value for Q3 2019.

  • On a quarterly basis, Return on Invested Capital fell 169.0% to 1.91% in Q3 2019 year-over-year; TTM through Sep 2019 was 1.91%, a 169.0% decrease, with the full-year FY2020 number at 0.83%, changed N/A from a year prior.
  • Return on Invested Capital was 1.91% for Q3 2019 at Palvella Therapeutics, down from 1.74% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.17% in Q2 2018 to a low of 4.08% in Q3 2017.
  • A 5-year average of 1.16% and a median of 0.74% in 2015 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 173545bps in 2015, then plummeted -169bps in 2019.
  • Palvella Therapeutics' Return on Invested Capital stood at 0.43% in 2015, then decreased by -22bps to 0.52% in 2016, then tumbled by -271bps to 1.94% in 2017, then surged by 65bps to 0.68% in 2018, then tumbled by -183bps to 1.91% in 2019.
  • Per Business Quant, the three most recent readings for PVLA's Return on Invested Capital are 1.91% (Q3 2019), 1.74% (Q2 2019), and 0.94% (Q1 2019).